Table 3 Tumor response assessed by Response Evaluation Criteria in Solid Tumors (version 1.1)
Full analysis set (n = 34) | PD -L1 CPS < 1 (n = 17) | PD -L1 CPS ≥ 1 (n = 12) | PD -L1 CPS < 5 (n = 22) | PD -L1 CPS ≥ 5 (n = 7) | |
|---|---|---|---|---|---|
Partial response, n (%) | 26 (76.5) | 12 (70.6) | 11 (91.7) | 16 (72.7) | 7 (100.0) |
Stable disease, n (%) | 5 (14.7) | 2 (11.8) | 1 (8.3) | 3 (13.6) | 0 |
Progressive disease, n (%) | 2 (5.9) | 2 (11.8) | 0 | 2 (9.1) | 0 |
Not evaluable, n (%) | 1 (2.9) | 1 (5.9) | 0 | 1 (4.5) | 0 |
Confirmed objective response rate, % (95% CI) | 76.5 (58.8–89.3) | 70.6 (44.0–89.7) | 91.7 (61.5–99.8) | 72.7 (49.8–89.3) | 100.0 (59.0–100.0) |
